Usage: CAVERJECT IMPULSE is indicated for treating erectile dysfunction and as an adjunct to other diagnostic tests for diagnosing erectile dysfunction.
Usage: CIBINQO is indicated for treating refractory, moderate-to-severe atopic dermatitis in adults and patients aged 12 and older, when the condition is not adequately managed by other systemic therapies or when those treatments are unsuitable. Co-use with other JAK inhibitors or biologics is not recommended.
Usage: DUAVEE is indicated for women with a uterus to treat moderate to severe vasomotor symptoms related to menopause and to prevent postmenopausal osteoporosis. It should be used for the shortest duration necessary, with periodic re-evaluation of treatment needs.
Usage: IBRANCE is indicated for adult patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer, used in combination with an aromatase inhibitor as initial therapy or fulvestrant after disease progression following endocrine therapy.
Usage: IBRANCE is indicated for treating adult patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer, either in combination with an aromatase inhibitor as initial endocrine therapy or with fulvestrant for those with disease progression after endocrine therapy.
Usage: LITFULO is indicated for treating severe alopecia areata in adults and adolescents aged 12 and older. It should not be used with other JAK inhibitors, biologic immunomodulators, cyclosporine, or potent immunosuppressants.